THE Australian Influenza Vaccination Committee has recommended the 2018 trivalent influenza vaccine for Australia should contain a combination of A (H1N1), A (H3N2) and B/Phuket like viruses, while the quadrivalent version should also add the B/Brisbane like virus.
The recommendations introduce a new A (H3N2) virus strain when compared to this year's version.
The TGA has accepted the committee's recommendations.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Oct 17